Oncology Reports · 2007 · 41 citations · 14 references
MedicineOncologyPharmacologyCancer PharmacologyChemotherapyMolecular OncologyChemotherapy ResistanceMalignant NeoplasmsOncogenic Signaling PathwaysOvarian CancerOvarian Cancer PharmacotherapyTumor BiologyOvarian Cancer ChemotherapyP-glycoprotein TransportTherapeutic Drug ResistanceTumor-associated Glycoproteins
We previously established that multicellular ovarian cancer spheroids develop intrinsic multidrug resistance with the appearance of quiescent cell areas. p27 protein is a determinant of such resistance. However, the precise molecular basis of such resistance remains unknown. We demonstrated herein that these multicellular ovarian cancer spheroids expressed high levels of p27 and P-gp protein. Compared with monolayer cells, there is a significant increase in the resistance of spheroids cells to anticancer reagent Taxol. Antisense oligodeoxynucleotide not only mediated down-regulation of p27, but also P-gp expression in multicellular spheroids. Selective small interfering RNAs (siRNA) of P-gp with MDR1-targeted short hairpin RNAs (shRNA) expression vector sensitized the cells to Taxol. These results suggest that both p27 and P-gp can modulate Taxol sensitivity respectively, while p27 requires P-gp for its full function. Increased P-gp protein expression through p27 mediation is one of the major mechanisms of Taxol resistance in ovarian cancer multicellular spheroids.
14
Effective expression of small interfering RNA in human cells
Cynthia P. Paul, Paul D. Good, Ira Winer et al. · Nature Biotechnology · 2002 · 825 citations
Absence of WAF1 mutations in a variety of human malignancies
Masaaki Shiohara, Wafik S. El‐Deiry, M Wada et al. · Blood · 1994 · 371 citations · Full text